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that actual vitamin A or zinc deficiencies are not common in these patients. Supplementation of selected 
patients may not improve night vision function to a degree noticeable by the patients and may produce 
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ABS'rRACT 
Eighteen adults with night vision complaints showed signifi-
cantly increased final rod thresholds as compared to their age-
and sex-matched controls, but vitamin A and zinc levels did not 
differ between the two groups. 
Vitamin A supplementation of three subjects produced changes 
in final rod thresholds and serum vitamin A levels, but these 
changes did not produce subjective improvements in night vision. 
It is concluded that patients with complaints about night 
vision often have increased final rod thresholds, but that actual 
vitamin A or zinc deficiencies are not common in these patients. 
Supplementation of selected patients may not improve night vision 
function to a degree noticeable by the patients and may produce 
unwanted side effects. 
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IN'rRODUCTION 
Occasionally, patients present to the optometrist with a con-
stellation of symptoms including an inability to see objects well 
at dusk, slow adaptation when entering dark rooms, and prolonged 
dazzle after passing a car with bright headlights. Usually these 
complaints are expressed in rather vague terms, and it is often 
difficult to decide if the patient has a "real" problem associated 
with dark adaptation or if the complaints are simply associated 
with aging (or perhaps changes in the weather or season) that might 
make night vision more difficult. 
If it can be determined that the patient's symptoms are "real" 
and that she is suffering from a form of night blindess*, the 
optometrist's first concern is to rule out frank genetic or acquired 
retinopathies. If this has been done, nutritional deficiencies 
should be considered. Traditionally, night blindness has been 
associated with inadequate vitamin A levels which can occur either 
because of insufficient dietary intake of the vitamin (primary 
deficiency) (1) or because the metabolism of vitamin A has been 
altered, 'possibly due to a zinc deficiency (secondary vitamin A 
deficiency). ( 2) 
In the body, vitamin A is stored in the liver and is delivered 
to the retina via the blood. In the photoreceptors, it is metabo-
lized to its aldehyde form (retinal) which is used for the formation 
*The term "night blindness" will ·be used in this paper to indicate 
a condition in which the patient has reduced ability to function 
in dim environments. Of course the patient is not "blind" at night 
just as a "color-blind" patient is not usually "blind" to all colors. 
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of the visual pigments. During light detection, quanta trigger 
the breakdown of the visual pigments into vitamin A and opsin. 
Most of the vitamin A is recycled, but, some is lost so a continuous 
dietary replacement is necessary for maintenance of proper blood 
and retinal levels. When dietary and blood levels of vitamin A 
are low, the amount of available pigment decreases causing, first, 
a change in rod function seen clinically as night blindness, and 
second, a change in cone function (3,4) if the vitamin A level 
declines even further. 
In addition to the need for vitamin A, sufficient zinc must 
also be available or night blindness can result (2). Zinc has two 
functions in the maintenance of proper vision. First, it is required 
to produce and mobilize retinol binding protein from the liver, 
and this protein is necessary to release vitamin A into the blood 
(5). Thus, without sufficient zinc, the vitamin A level in the 
blood may be too low to support proper retinal function. Second, 
zinc is a required component of the enzyme retinol dehydrogenase 
which converts retinol from the blood to retinal needed to make 
the visual pigments. Low zinc levels can cause reduced activity 
of this enzyme (6), and thus cause night blindness by decreasing 
the amount of available visual pigment in the retina. 
Although supplementation with vitamin A and/or zinc is useful 
in cases of gross nutrient deficiencies (7,8), little is known 
about treatment in cases of marg~nal deficiencies. Thus, it is 
difficult for the optometrist to know whether nutritional testing, 
counseling and treatment are appropriate for her patients who have 
night vision complaints. To investigate vitamin A and zinc nutriture 
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in such patients and to evaluate vitamin A supplementation therapy 
for selected patients, the following study was designed. Three 
specific questions were asked: 
1. Can the night vision complaints of patients who do not have 
frank pathologies typically be verified by using standard 
clinical testing procedures? 
2. Do patients with verifiable night blindness complaints (and no 
frank pathologies) typically have abnormal vitamin A or zinc 
nutriture? 
3. Will vitamin A supplementation alleviate the complaints and prob-
lems of these patients? 
SUBJECTS 
Information regarding this research project was placed in 
several local newspapers, and persons who felt that they could not 
see well at night were asked to contact the experimenters. From 
the approximately 30 people who responded, 18 experimental subjects 
were selected. Fifteen were females and 3 were males (mean age 
32, range 24 to 46 years). Selection of subjects was based on the 
following series of evaluations which were intended to rule out 
patients with psychological, pathological or night myopia problems: 
1. Each potential subject was interviewed to assess the level of 
her/his night vision complaints. Specific questions involved 
situations in which the subject and another person were standing 
next to each other in a dim environment and viewing identical 
objects such as road signs. Each potential subject had to 
strongly indicate that in comparison situations such as these, 
their night vision was much worse than that of peers. 
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2. During the interview, it wao also determined that each potential 
subject was in good physical health and that there was no 
known family history of eye disease or night blindness. 
3. To insure clear media and to rule out ocular pathology, each 
subject was required to have best correctable visual acuity of 
20/20, ophthalmoscopy had to reveal clear media and normal ocular 
structures, and no subject could be more than 50 years of age. 
4. Since night myopia may cause complaints similar to night blind-
ness, potential subjects with night myopia were eliminated by 
use of a bichrome test in which a dim 20/40 line was project-
ed in a darkened room. To be used in the experiment, .the sub-
ject's red/green balance under these conditions had to be with-
in 0.25D of the best subjective refraction obtained under 
normal testing conditions. 
The 18 subjects who met these requirements were age-and sex-
matched to normal control subjects who had no complaints of night 
vision problems and who were free from pathologies. 
METHODS 
Dark adaptometry 
To verify the subject's complaints of night blindness, a 
Goldmann-Weekers Adaptometer was used to measure final rod and 
cone thesholds and the time to the shift from cone to rod vision. 
Each of the subjects was prepared for adaptometry by using 
0. 5% tropicamide to dilate one pupi.l to a diameter of at least 7 mm. 
The non-dilated eye was patchedJand the subject was preadapted in 
the adaptometer for 5 minutes using a diffuse white 200 millilambert 
light. The subject was then asked to fixate a small red spot 
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displaced 20° superior from the center of the ganzfeld, and a 
flashing 11.0 degree white spot was used to determine the threshold 
at one minute intervals following the start of the adaptation 
cycle. Threshold changes were monitored for 35 minutes or until a 
stable final rod threshold had been reached. For each of the 
experimental and control subjects, log thresholds were plotted 
against time, and these curves were used to determine the final 
thresholds and the time to the rod-cone breaks. 
Vitamin A Assessment 
Dietary intake and blood serum levels were used to determine 
each subject's vitamin A nutriture. Dietary intake of vitamin A 
was assessed by using a computerized analysis in which each subject 
was asked to complete a food frequency questionnaire on their 
daily, weekly, and/or monthly consumption of specific food types. 
The subjects were also asked to include reports on any nutritional 
supplements that they were currently taking. 
To determine serum levels of vitamin A, blood samples were 
drawn from each subject and analyzed by the use of fluorometric (9) 
or spectrophotometric procedures (10,11). 
Zinc Assessment 
Zinc nutriture was assessed using dietary and hair analyses~ 
The dietary analysis was the same one used for the vitamin A assess-
ment with special care taken to insure that all mineral supplements 
were reported. Since the level of zinc in the hair is a good in-
dicator of the averaged intracellular zinc level (12), one gram of 
recent hair growth was cut from the suboccipital region of the 
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head, washed, digested in acid, and the zinc level determined by 
atomic absorption spectrophotometry (12). 
RESULTS 
Figure 1 presents the results from the dark adaptometry, 
Insert Figure 1 about here 
vitamin A, and zinc tests. Dark adaptometry data do not reveal any 
significant differences between the control and experimental sub-
jects in final cone thresholds or rod-cone break times, but there 
is a significant difference in final rod thresholds. Subjects who 
had complaints of an inability to see well at night had a mean 
threshold 0.4 log unit higher than their age-and sex-matched con-
trols. This finding substantiates the subjects' complaints of 
night vision problems.** 
The results of the vitamin A and zinc analyses indicate that 
both experimental and control subjects consumed more than the 
recommended daily allowance of both vitamin A and zinc and that 
their serum and hair levels were within normal ranges. Thus, 
while the experimental subjects did have a verifiable increase in 
final rod threshold, they did not differ from their matched controls 
in vitamin A or zinc nutriture. 
**The effects of such a loss can be demonstrated by placing a 0.4 ND 
Wratten filter in front of one completely dark-adapted eye. A com-
parison can then be made between scenes viewed with and without the 
filter. 
· Fi9ure 1 
Results of Dark Adaptometry and Nutritional Assessment 
for Subjects With and Without Complaints of Night Blindness 
DARK ADAPTOMETRY 
Normal 
Range 
Subjects 
With 
Complaints 
Subjects 
Without 
Complaints Significance 
CONE THRESHOLD 
(log cd/m2) 
-2.04- -2.6o(a) -2.2 (.3)(b) 
BREAK TIME 
(seconds) 
FINAL ROD THRESHOLD 
6-8 (c) 6.6 (2) 
(log cdjm2) -5.17- -5.37(a) -4. 8 (. 3) 
INTAKE ( IU/day) 
BLOOD SERUM 
(ug/dl) 
INTAKE 
(mg/day) 
HAIR 
(mg%) 
VITAMIN A 
4000-females(d) 12152 {6340) 
5000-males 
20-80 (e) 57 (24) 
ZINC 
15 (d) 16 (8) 
16-24 (e) 23 (11) 
(a) (Reference 4) 
-2.2 (.3) 
6.8 {3) 
-5.2 (.2) 
11141 {8871) 
68 ( 3 3) 
18 ( 19) 
22 ( 9) 
(b) The first value is the mean; the value in parenthesis is the 
standard deviation. 
(c) (Reference 13) 
(d) Recommended Daily Allowance established by National Academy of 
Sciences 
(e) Established by laboratory performing analysis 
NS 
NS 
p .OS 
NS 
NS 
NS 
NS 
_1. 
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VITAMIN A SUPPLEMENTATION 
Even though the experimental subjects did not have "abnormal" 
levels of vitamin A or zinc, the possibility still remained that 
these subjects required higher than "normal" levels of these sub-
stances for proper retinal function. To evaluate the possibility 
that the experimental subjects could benefit from taking large 
doses of vitamin A, they were asked to participate in an additional 
experiment involving vitamin A supplementation. Five of the subjects 
agreed to participate. 
The supplementation and testing schedule for these subjects 
is outlined in Figure 2. A serum biochemical screen was used to 
Insert Figure 2 about here 
rule out any contraindications to vitamin A supplementation (14), 
and, later in the experiment, it was used to insure that the vitamin A 
supplementation was not producing any unwanted changes in blood 
chemistry. 
The supplementation experiment used a single-blind design in 
which subjects received a daily placebo dose of 200 mg of vitamin C 
for one month prior to receiving vitamin A supplementation.*** 
Following this month, subjects received a "high" daily dose of 
40,000 IU of vitamin A for one month after which they received 
10,000 IU daily for a two month maintenance period. The subjects 
were examined at the end of each supple~entation phase as shown 
in Figure 2. During each examination, dark adaptometry was 
***Subjects were aware that they might be receiving a placebo for 
part of the experimental period, but were not aware of when in the 
experiment this might occur. At no point were they told whether 
they were receiving vitamin A or vitamin C_, and the tablets were 
disguised so as to make it impossible for them to make this deter-
mination on their own. 
Visit 
number 
1 
2 
3 
4 
Figure 2 
Supplementation and Testing Schedule 
Total Time Tests Supplementation 
Elapsed Performed Started 
0 months Dark adaptometry Vitamin c 
Serum biochemical 200 mg/day 
screen for 1 month 
Questionnaire on 
symptoms 
1 month Dark adaptometry Vitamin A 
Serum biochemical 40,000 IU/day 
screen for 1 month 
Serum vitamin A 
level 
Questionnaire on 
symptoms 
2 months Dark adaptometry Vitamin A 
Serum biochemical 10,000 IU/day 
screen for 2 months 
Serum vitamin A 
level 
Questionnaire on 
symptoms 
4 months Dark adaptometry 
Serum vitamin A 
level 
Questionnaire on 
symptoms 
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performed and the subjects completed a rating scale questionnaire 
regarding their ability to perform common tasks in dim light. 
Ther~ Vlere fourteen items on the questionnaire. Twelve items were 
questions involving specific situations, and two items were ques-
tions about the general performance of the subject in dim illumi-
nation. Subjects responded to each item using ten point rating 
scales with appropriate verbal anchors provided at both ends and 
the midpoint of the scales. Results of the questionnaire were 
evaluated by comparing subjects' ratings before, during and 
after supplementation. 
Of the 5 subjects who began the supplementation phase of the 
study, three completed it. One subject (SK) dropped out because 
of a skin rash that developed after she began taking the high dose 
of vitamin A (14) and another (SL) was concerned about a possible 
increase in intracranial pressure that occurred while she was 
taking the vitamin C placebo. Her physician suggested that she 
should not take the high doses of vitamin A since a toxic side 
effect of such supplementation can be increased intracranial pres-
sure (14). 
The results of vitamin A supplementation for the remaining 
three subjects are summarized in the following case reports: 
Case 1 - TJ was a normal 41 year old female with specific 
complaints of difficulty when walking at night and slow adaptation 
to large luminance decreases (e.g. when entering a movie theatre) . 
... 
Her initial vitami,n A_and zinc levels were normal (Figure 3) but 
Insert Figure 3 about here 
l''igure 3 
Final rod thresholds and vitamin A serum levels for subjects 
participating in the supplementation study. Note that there are 
only small changes in the final rod thresholds measured before and 
after the vitamin C placebo. This indicates ~ood repeat-measure 
reliability for the adaptometry. Arrows placed next to the thres-
hold curves represent mean final rod thresholds for the experi-
mental and control groups. Initials in parenthesis next to each 
curve represent the subjects referred to in the text. 
~ -4.4 
0 
~ ... -4.6 
wN 
a: E 
:X: ... -4.8 
... ~ 
c a -5.0 
0 0 
a:;:; 
..J -5.2 
c( 
~ -5.4 
92 
~ 
~ 84 
"' :I 
.... 
c( 
... 76 
> 
::::E 
::I 
a: 68 
w 
rn 
60 
L-~-V-IT---c,--HI~G~H~-M-A_I_N_T __ V-IT---,A 
VIT-A 
START 
SUPPLEMENTATION 
• HL 
* TJ 
e MA 
2 
MPNTHS 
4 
EXP 
._MEAN 
CNTRL 
._MEAN 
NORMAL 
RANGE 
47-113 
ug/dl 
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• her final rod threshold was 0.3 log unit above that for her age 
and sex matched control. 
Following high dose vitamin A supplementation, her serum level 
increased and her final rod threshold decreased to a value equal 
to that of her control. During the maintenance period, her vitamin A 
serum level continued to increase, but her final rod threshold in-
creased slightly. 
Contrary to expectation, her responses on the rating scale 
questionnaire did not reflect the improved vitamin A and threshold 
levels. In fact, TJ indicated that her night vision difficulties 
became slightly worse during the vitamin A supplementation. Prior 
to supplementation she rated her overall ability to see in dim 
light as 5 on the 10 point scale (1 equals "not difficult", 10 
equals "extremely difficult"), but following supplementation, her 
rating rose to 8. 
Case 2 - The second subject, MA, was a normal 29 year old female 
with complaints associated with night driving. At the time of her 
initial ~valuation, zinc and vitamin A levels were within the 
normal range. Her final rod threshold was, however, 0.2 log units 
above the threshold for her matched control subject. 
Supplementation with the high dose of vitamin A produced the 
expected increase in the serum level and a 0.1 log .unit decrease 
in threshold. MA's threshold continued to decrease during the two 
month maintenance period until it reached -5.3 log cd/m2. 
Just as with subject TJ, MA did not notice differences in 
her night vision corresponding to the decrease in final rod thres-
hold or the increase in serum vitamin A level. From the beginning 
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of the study to the end neither her overall night vision rating 
nor her night driving rating changed. 
Case 3 - Subject HL was a normal 26 year old female who indicated 
that she had problems performing almost any task in dim light. 
Initially, her vitamin A levels and her dietary intake of zinc were 
normal, but she had a zinc hair level of 31 mg% which suggested a 
systemic zinc deficiency. The normal range of the hair zinc level 
is 16-24 mg% with both higher and lower values indicating systemic 
deficiency (12). Prior to starting vitamin A supplementation, her 
final rod threshold was -4.9 log cd/m2 which was 0.3 log unit above 
the comparable level for her control subject. After one month of 
high dose vitamin A supplementation, her final rod threshold had 
increased to -4.6 log cd/m2 indicating that her night vision had 
worsened. This occurred even though HL's vitamin A serum level 
had increased as a result of supplementation. Following the two 
month maintenance period, HL's f~nal rod threshold was -4.7 log 
cd/m2 and her vitamin A serum level remained at 85 ug/dl, but 
she reported that her night vision had become worse during the 
course of the study. Her overall night vision rating was 4 on the 
intial visit but on the final visit she rated her ability to see 
in dim light as 9. (A rating of 1 equals "not difficult" and 10 
equals "extremely difficult".) 
In summary, these case reports suggest that vitamin A supple-
mentation for subjects who have normal vitamin A levels may not 
produce noticeable improvements in night vision. While it is 
possible to increase the level of vitamin A in the blood serum, 
none of the three subjects reported corresponding increases in 
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vision, and two of them actually felt that their vision had deteri-
orated during the vitamin A supplementation. 
DISCUSSION 
We studied a group of subjects who complained that their night 
vision was worse than that of their peers. The severity of their 
symptoms was not extreme enough to debilitate any of the subjects, 
and only a few had sought professional help prior to participation 
in the study. Thus, these subjects represent a group of patients 
who might complain of night vision problems in an optometric exami-
nation, but who probably would not make it the major reason for 
coming to the optometrist. 
The experimental subjects did, however, have real night vision 
problems as demonstrated by the fact that their mean final rod 
threshold was 0.4 log unit worse than the comparable threshold 
for the age- and sex-matched controls. This suggests that "normal" 
patients who present with vague night vision complaints may have 
"real" problems which should be evaluated. Whether such an evalu-
ation should include the expensive vitamin A and zinc nutriture 
tests used in this study is questionable since the majority of 
patients with reduced final rod thresholds were not found to have 
abnormal vitamin A or zinc levels. 
The question of whether nutritional supplementation of other-
wise normal patients with night complaints is beneficial also re-
mains open. Of the five subjects who received vitamin A supplemen-
tation, at least one experienced an adverse (but easily reversible) 
reaction to the high vitamin A doses and none of the subjects 
-12-
reported a decrease in their night vision complaints during supple-
mentation. 
In conclusion, we feel that vague patient complaints of night 
vision difficulties should be regarded as "real" by the optometrist, 
but that the universal use of vitamin A supplementation for such 
patients is questionable; the risks of high dose vitamin A supple-
mentation must be weighed against any possible benefits. Based on 
our limited number of subjects, we suggest that such risks may 
outweigh the benefits for patients who have normal vitamin A levels 
prior to supplementation. 
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